Stock
Stock

阿里拉姆制药

398.00

Delay
0
Open
410.00
Market Cap
52.48B+
High
410.04
Low
387.03
Close
397.55
Volume
1.60M+
P/E Ratio
-182.36
Div/Yield
0.00%
Track The Stock Movement

About 阿里拉姆制药

Alnylam制药公司是一家全球商业阶段的生物制药公司,从事RNAi疗法的发现、开发和商业化。其产品包括ONPATTRO、GIVLAARI和OXLUMO。该公司由诺贝尔桂冠、大卫·巴特尔、托马斯·图希尔、菲利普·扎莫尔、保罗·R·施梅尔和菲利普·A·夏普于2002年6月14日创立,总部设在马萨诸塞州剑桥市。

Trade GPT

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.